EV/EBITDA
N/A
8 min ago
Summary
- APTO EV/EBITDA is not available.
Performance
APTO EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
APTO EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | - | - | +3.4% |
| 1 m1 month | - | - | -19.4% |
| 3 m3 months | - | - | -52.3% |
| 6 m6 months | - | - | -62.1% |
| ytdytd | - | - | -20.1% |
| 1 y1 year | - | - | -91.5% |
| 5 y5 years | - | - | -97.4% |
APTO EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | ||||
| 3 m | 3-month | ||||
| 6 m | 6-month | 0.04 | -0.12 | ||
| 1 y | 1-year | 0.04 | -0.49 | ||
| 3 y | 3-year | 0.77 | -0.53 | ||
| 5 y | 5-year | 2.07 | -0.53 | ||
| alltime | all time | 21.16 | -3.73 |
Aptose Biosciences EV/EBITDA History
| Date | Value |
|---|---|
| 2023 | -0.23(-130.3%) |
| 2022 | 0.76(+61.7%) |
| 2021 | 0.47(-71.3%) |
| 2020 | 1.64(-13.2%) |
| 2019 | 1.89(+425.0%) |
| 2018 | 0.36(-35.7%) |
| 2017 | 0.56(+24.4%) |
| 2016 | 0.45(-13.5%) |
| 2015 | 0.52(-326.1%) |
| 2013 | -0.23(-154.8%) |
| 2012 | 0.42(+281.8%) |
| Date | Value |
|---|---|
| 2011 | 0.11(-35.3%) |
| 2010 | 0.17(-15.0%) |
| 2009 | 0.20(-130.3%) |
| 2008 | -0.66(-53.2%) |
| 2007 | -1.41(+74.1%) |
| 2006 | -0.81(+285.7%) |
| 2005 | -0.21(-12.5%) |
| 2004 | -0.24(-91.1%) |
| 2003 | -2.70(+2354.5%) |
| 2002 | -0.11(-83.6%) |
| 2001 | -0.67(-46.8%) |
| 2000 | -1.26 |
FAQ
- What is the all time high EV/EBITDA for Aptose Biosciences?
What is the all time high EV/EBITDA for Aptose Biosciences?
Aptose Biosciences all-time high EV/EBITDA is 21.16